News Focus
News Focus
Replies to #61656 on Biotech Values
icon url

DewDiligence

04/21/08 3:07 PM

#61663 RE: 10nisman #61656

Re: IDIX coverage initiated at Caris & Company with $19 target

I’m bullish on IDIX but I can’t see the share price attaining $19 this year—or ever. The most likely outcome, IMO, is that NVS eventually buys the 44% of the company it does not already own for a price in the low teens.

The standstill agreement that prevents NVS from making a move to increase its IDIX stake expires on 8-May-2008.